ENFOQIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Apr 2024)
What this means for you
This application is over — abandoned 08 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88783014
- Mark type
- Stylized text
- Filed
- 03 Feb 2020
- Published for opposition
- 05 Jan 2021
- Abandoned
- 08 Apr 2024
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)
Owner
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
Prosecution history
- 08 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Sept 2023 — SOU EXTENSION 5 GRANTED
- 28 Aug 2023 — SOU EXTENSION 5 FILED
- 07 Sept 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2023 — SOU EXTENSION 4 GRANTED
- 14 Feb 2023 — SOU EXTENSION 4 FILED
- 14 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2023 — ASSIGNED TO EXAMINER
- 25 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2022 — SOU EXTENSION 3 GRANTED
- 23 Aug 2022 — SOU EXTENSION 3 FILED